NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,096 filers reported holding NOVARTIS A G in Q2 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $136,000 | -92.6% | 1,655 | -91.5% | 0.01% | -87.0% |
| Q4 2019 | $1,842,000 | +165.0% | 19,455 | +143.2% | 0.07% | +122.6% |
| Q3 2019 | $695,000 | -74.3% | 8,000 | -73.0% | 0.03% | -76.7% |
| Q2 2019 | $2,708,000 | +57.0% | 29,656 | +65.3% | 0.13% | +37.1% |
| Q1 2019 | $1,725,000 | +22.1% | 17,938 | +8.9% | 0.10% | +2.1% |
| Q4 2018 | $1,413,000 | +443.5% | 16,468 | +445.7% | 0.10% | +533.3% |
| Q3 2018 | $260,000 | -78.8% | 3,018 | -81.4% | 0.02% | -80.8% |
| Q2 2018 | $1,226,000 | +22.0% | 16,227 | +30.6% | 0.08% | +6.8% |
| Q1 2018 | $1,005,000 | +66.1% | 12,428 | +76.3% | 0.07% | +32.7% |
| Q3 2017 | $605,000 | +8542.9% | 7,049 | +8602.5% | 0.06% | +5400.0% |
| Q2 2017 | $7,000 | -98.5% | 81 | -98.3% | 0.00% | -98.5% |
| Q2 2015 | $471,000 | -0.2% | 4,789 | 0.0% | 0.07% | +1.5% |
| Q1 2015 | $472,000 | – | 4,789 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |